Cargando…

The use of malignant serosal fluid as a tumor vaccine in patients with advance malignancies

Detalles Bibliográficos
Autor principal:	Katakkar, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652549/ http://dx.doi.org/10.1186/2051-1426-3-S2-P439

Ejemplares similares

Recruiting patients with advanced malignant and non-malignant disease: lessons learned from a palliative care RCT
por: Farquhar, Morag C, et al.
Publicado: (2011)

Tumors of the serosal membranes
por: Battifora, Hector
Publicado: (1995)

Diagnostic Utility of Combined CEA, CA15-3 and CA125 Biomarkers and Cytomorphology in Suspicious and Malignant Serosal Fluid
por: Rahemi, Zahra, et al.
Publicado: (2021)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

Limping as the first manifestation of malignant round cell tumor
por: Mahboobi, Leila, et al.
Publicado: (2014)

Differences in MR perfusion of malignant and benign cardiac tumors
por: Bauner, Kerstin U, et al.
Publicado: (2009)

Simultaneous determination of two serum tumor markers in assessing malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)

Selective killing of malignant B cells using T cells redirected against malignancy variant receptor
por: Han, Chungyong, et al.
Publicado: (2014)

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
por: Burris, Howard, et al.
Publicado: (2013)

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors
por: Ansell, Stephen, et al.
Publicado: (2013)

Reducing error: benign abnormalities mimicking malignancy when reporting scans of patients with known malignancy
por: Jenkins, S, et al.
Publicado: (2015)

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
por: Bjørn, Jon, et al.
Publicado: (2013)

Evaluation of the factors affecting the prognosis of patients with solid tumors and hematologic malignancies in the intensive care unit
por: Savran, Y, et al.
Publicado: (2015)

Outcomes of patients with hematologic malignancies admitted to the ICU
por: Duayer, I, et al.
Publicado: (2015)

Is intensive care beneficial for patients with haematologic malignancies?
por: Nyunga, M, et al.
Publicado: (2010)

Outcome of septic shock in patients with malignancies and neutropenia
por: Furmanchuk, D
Publicado: (2005)

Prognosis of patients with haematological malignancies admitted to the ICU
por: Geerse, DA, et al.
Publicado: (2008)

Use of ultrasound in the assessment of screen-detected malignant microcalcifications
por: Mvere, MZ, et al.
Publicado: (2012)

Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014)

Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
por: Letsch, Anne, et al.
Publicado: (2013)

Is hyperlactatemia a useful screening marker of severe sepsis in hemato-oncologic malignant patients?
por: Park, S, et al.
Publicado: (2015)

Development of a malignant hyperthermia protocol
por: Yeung, EYH, et al.
Publicado: (2015)

Postoperative acute kidney injury in patients with gynecologic malignancies
por: Didik, M, et al.
Publicado: (2014)

Outcome of patients with haematological malignancy admitted to the general ICU
por: Ketchley, I, et al.
Publicado: (2008)

Polyorromenitis or Multiple Serositis
por: Matthew, Edwin
Publicado: (1912)

Pamidronate therapy for hypercalcemia of childhood malignancy
por: Sng, Andrew, et al.
Publicado: (2015)

Malignant melanoma: an audit on delay in diagnosis
por: Lee, CWC, et al.
Publicado: (2015)

Is admission of hematologic malignancies in the ICU justified?
por: Gasparovic, VG, et al.
Publicado: (2015)

Gastric adenocarcinoma is not an HIV related malignancy
por: Kayamba, Violet, et al.
Publicado: (2012)

Predictors of poor outcomes in critically ill patients with hematologic malignancy
por: Cornish, M, et al.
Publicado: (2015)

Outcome of patients with metastatic cancer or haematological malignancy in intensive care
por: Meynaar, I, et al.
Publicado: (2009)

Predictors of outcome in patients with haematological malignancies admitted to critical care
por: Tridente, A, et al.
Publicado: (2014)

Retrospective study of the outcomes of patients admitted to the ICU with a hematological malignancy
por: Lewis, H, et al.
Publicado: (2012)

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013
por: Ribrag, Vincent, et al.
Publicado: (2015)

Changes in incidence and prognosis of malignancies in children with HIV
por: Stefan, Daniela C, et al.
Publicado: (2012)

100 telephone conversations about malignant hyperthermia
por: Petersen, Bodil, et al.
Publicado: (2014)

Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)

Prognosis of Elderly Patients with Advanced Gastric Cancer without Serosal Invasion
por: Kim, Ho Gun, et al.
Publicado: (2022)

Outcome of critically ill patients with haematological malignancy admitted to the ICU as an emergency
por: Lofaro, T, et al.
Publicado: (2013)

Early risk stratification in patients with oncological and hematological malignancies in the emergency department
por: Rast, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gp0ddglk8akg04auajupg81eoa